Sarcoma trials in Costa Rica

2 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

  Where

  San José

  Age

  18 years and over

  People

  348 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06345729 · EU 2023-507776-42-00
• No phaseTaking people
  Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK

  Where

  Heredia

  Age

  18 years to 120 years

  People

  5,000 worldwide

  Run by

  Grupo Espanol de Investigacion en Sarcomas

  See details and how to joinNCT04181970